Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

Inclusion Criteria

• •Participants enrolled in Detroit Research on Cancer Survivors (Detroit ROCS)
• •Diagnosis of Primary Breast, prostate, or colorectal cancer on or after 1/1/2013
• •have received or currently receiving care at Karmanos Cancer Institute
• •meet one or more of the National Comprehensive Cancer Network (NCCN) guidelines for cancer genetic testing as described below
• •Female breast
• •1. personal diagnosis at age ≤50
• •2. personal history of the triple-negative subtype
• •3. at least 1 close (first- or second-degree) relative diagnosed with breast cancer at age \<50
• •4. at least 1 close relative diagnosed with ovarian cancer
• •5. 2+ close relatives diagnosed with breast or prostate cancer
• •6. age \<50 AND another primary breast cancer at any age
• •7. 2+ primary breast cancers at any age
• •OR Prostate
• •1. personal history of high-risk or very high-risk prostate cancer
• •2. personal history of regional or metastatic prostate cancer
• •3. personal history of less than high-risk prostate cancer with a suggestive family history (i.e., father or brother or multiple relatives with prostate cancer diagnosed at age \<60; at least 1 relative with breast, ovarian, or pancreatic cancer; or at least 1 relative with colorectal, ovarian, pancreatic, or kidney cancer)
• •OR Colorectal
• •1. personal diagnosis at age ≤50
• •2. at least 1 close relative diagnosed with HNPCC at age \<50
• •3. at least 2 close relatives diagnosed with an HNPCC cancer at any age
• •4. colorectal and \>=1 primary endometrial, ovarian, gastric, pancreatic, or prostate